Who is sponsoring NCT03962075?

NCT03962075 is sponsored by Zagazig University.

What drugs are being tested in NCT03962075?

Interventions in NCT03962075: laparoscopic paravaginal repair.

What condition does NCT03962075 study?

NCT03962075 studies Prolapse, Vaginal, Paravaginal Cystocele.

Is NCT03962075 still recruiting?

NCT03962075 is currently completed. Last updated 23 May 2019.

Last reviewed 2019-05-23 · How we verify

NCT03962075

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Short-term Outcomes of Laparoscopic Repair of Paravaginal Defects

Completed NA Last updated 23 May 2019

What this trial tests

NA trial testing laparoscopic paravaginal repair in Prolapse, Vaginal in 50 participants. Completed in 10 May 2018.

Timeline

1 August 2016

Primary endpoint
20 February 2018

10 May 2018

Quick facts

Lead sponsor	Zagazig University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 August 2016
Primary completion	20 February 2018
Estimated completion	10 May 2018

Drugs / interventions tested

laparoscopic paravaginal repair

Conditions studied

Prolapse, Vaginal — all drugs for Prolapse, Vaginal →
Paravaginal Cystocele — all drugs for Paravaginal Cystocele →

Sponsor

Zagazig University

Who can join

Adults 20 to 50, female only, with Prolapse, Vaginal or Paravaginal Cystocele. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study designed To evaluate the efficacy and outcomes of laparoscopic approach for repair of paravaginal defects associated with anterior vaginal wall prolapse.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Prolapse, Vaginal

Currently open trials in the same condition.

NCT07071818 — Transperineal Ultrasound Evaluation of Vesicourethral Angle and de Novo SUI After Colpocleisis Surgery · NA · recruiting
NCT07067645 — Post-Hysterectomy Vaginal Length: Horizontal vs. Vertical Closure · NA · recruiting
NCT06416982 — Perineal Massage for Pessary Examinations · NA · active not recruiting
NCT03875989 — Vaginal Native Tissues Repair for Pelvic Organ Prolapse · NA · recruiting

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03962075 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 23 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03962075.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing